20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9808 | Tetradecylthioacetic acid | PPAR | |
Tetradecylthioacetic acid is a synthetic fatty acid with a sulfur substitution in the β-position. This modification renders TTA unable to undergo complete β-oxidation and increases its biological activity, including acti... | |||
T10035 | 10,12-Tricosadiynoic acid | TDA,TCDA | Acyltransferase |
10,12-Tricosadiynoic acid is a highly selective and orally active inhibitor of acyl-CoA oxidase-1 (ACOX1). It can treat the high-fat diet- or obesity-induced metabolic diseases by improving mitochondrial lipid and ROS me... | |||
T4535 | Etomoxir sodium salt | (R)-Etomoxir sodium salt,Na salt,Etomoxir | Apoptosis , Others |
Etomoxir sodium salt ((R)-Etomoxir sodium salt) is a carnitine palmitoyltransferase 1a (CPT-1a) inhibitor that blocks fatty acid synthesis. Etomoxir sodium salt has antitumor activity. | |||
T1889 | CP-640186 | CP 640186 | Acetyl-CoA Carboxylase |
CP-640186 is an isozyme-nonselective Acetyl-CoA carboxylase (ACCase) inhibitor. The IC50s of CP-640186(CP 640186) is 53 nM and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2 respectively. | |||
T3622 | CP-640186 hydrochloride | CP 640186 HCl | Acetyl-CoA Carboxylase |
CP-640186 hydrochloride (CP 640186 HCl) is an isozyme-nonselective acetyl-CoA carboxylase (ACC) inhibitor, including rat liver ACC1 (IC50: 53 nM) and rat skeletal muscle ACC2 (IC50: 61 nM); with higher metabolic stabilit... | |||
T9768L | Ninerafaxstat trihydrochloride | Ninerafaxstat trihydrochloride(2254741-41-6 Free base) | Others |
Ninerafaxstat trihydrochloride shifts cellular metabolism to glucose oxidation from fatty acid oxidation. Ninerafaxstat trihydrochloride improves overall mitochondrial respiration and reduces fatty acid oxidation, thereb... | |||
T19663 | Triheptanoin | UX 007,IND106011,UX007,UX-007,IND 106011,IND-106011 | Others |
Triheptanoin (IND 106011) is a fatty acid metabolic modulator. It potentially for the treatment of fatty acid oxidation disorders and GLUT1. | |||
T12356 | Palmitoylcarnitine | Palmitoyl DL-carnitine | Endogenous Metabolite |
Palmitoylcarnitine (Palmitoyl DL-carnitine) is a mitochondrial fatty acid oxidation intermediate that acts as a surfactant. | |||
T15157 | Dodecanoylcarnitine | Lauroylcarnitine | Endogenous Metabolite |
Dodecanoylcarnitine ((-)-Lauroylcarnitine) has been associated with disturbances in fatty acid oxidation, and the use of Dodecanoylcarnitine resulted in an increase in the permeability of salmon calcitonin. | |||
T5246 | Trans-2-butene-1,4-dicarboxylic acid | trans-2-Butene-1,4-dicarboxylic Acid,3-Hexenedioic Acid,trans-3-Hexenedioic Acid,β-Hydromuconic Acid | Others , Endogenous Metabolite |
Trans-2-butene-1,4-dicarboxylic acid (3-Hexenedioic Acid) is a normal human unsaturated dicarboxylic acid metabolite with increased excretion in patients with Dicarboxylic aciduria caused by fatty acid metabolism disorde... | |||
TN2374 | Methyl Linolenate | Linolenic acid methyl ester | Others |
Methyl Linolenate (Linolenic acid methyl ester) is a polyunsaturated fattly acid (PUFA). It is used in studies on the mechanisms and prevention of oxidation/peroxidation of unsaturated fatty acids. | |||
T21468 | CVT-2738 | UNII-NYS3I6283H,CVT 2738,EC 610-916-8,CVT2738,RS-94287 | Others |
CVT-2738 (RS-94287) is a metabolite of Ranolazine. Ranolazine is a partial fatty acid oxidation (pFOX) inhibitor and anti-anginal drug. | |||
T5226 | 2-(2-Methylbenzamido)acetic acid | 2-Methylhippuric acid,O-Toluric acid,N-(O-Toluoyl)glycine | Others , Endogenous Metabolite |
2-(2-Methylbenzamido)acetic acid (O-Toluric acid) is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. In certain cases, the measurement of these metabolites in body fluids can be used to diag... | |||
T4944 | Nervonic acid | cis-15-Tetracosenoic acid,Selacholeic acid | Endogenous Metabolite |
Nervonic acid (Selacholeic acid) is a long chain unsaturated fatty acid that is enriched in sphingomyelin. It consists of choline, sphingosine, phosphoric acid, and fatty acid. Nervonic acid may enhance the brain functio... | |||
T0846 | L-Carnitine | L(-)-Carnitine,Levocarnitine | Endogenous Metabolite , Fatty Acid Synthase |
L-Carnitine (L(-)-Carnitine) is an amino acid derivative. L-Carnitine facilitates long-chain fatty acid entry into mitochondria, delivering substrate for oxidation and subsequent energy production. Fatty acids are utiliz... | |||
T13810 | Palmitoylcarnitine chloride | Palmitoyl DL-carnitine chloride | PKC |
Palmitoylcarnitine chloride (Palmitoyl DL-carnitine chloride) is a mitochondrial fatty acid oxidation intermediate that mediates intralipid cardioprotection.Palmitoylcarnitine chloride eliminates colorectal cancer cell s... | |||
T4734 | Suberic acid | Octanedioic acid,1,8-Octanedioic acid | Others , Endogenous Metabolite |
Suberic acid (1,8-Octanedioic acid) is present in the urine of patients with fatty acid oxidation disorders. A metabolic breakdown product derived from oleic acid. Elevated levels of this unstaruated dicarboxylic acid ar... | |||
T4535L | Etomoxir | (R)-(+)-Etomoxir | Antioxidant , CPT |
Etomoxir is a carnitine palmitoyltransferase 1a (CPT-1a) inhibitor that inhibits fatty acid oxidation by inhibiting CPT-1a and inhibits palmitate oxidation in humans, rats, and guinea pigs. Etomoxir has an inhibitory eff... | |||
T5245 | N-Isovaleroylglycine | Isovaleroylglycine,N-Isovalerylglycine | Others , Endogenous Metabolite |
N-Isovaleroylglycine (Isovaleroylglycine) is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metaboli... | |||
T36831 | 9-Oxononanoic Acid | 9-ONA | Phospholipase , CPT |
9-Oxononanoic Acid is an oxidized fatty acid, formed by the autoxidation of linoleic acid, which enhances phospholipase A2 (PLA2) activity and increases the production of thromboxane B2 in isolated human plasma.9-Oxonona... |